Letter to Editor, Re: The first report on Covid-19 vaccine refusal by cancer patients in Italy: Early data from a single-institute survey: Educational Webinar about COVID-19 Vaccines in Oncological Patients: A Promising Strategy to Tackle COVID-19 Vaccine Hesitancy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

1. Vaccine hesitancy in cancer patients: A rapid review.Patient education and counseling · 2023
   Review
2. Experiences and perspectives of cancer stakeholders regarding COVID-19 vaccination.Asia-Pacific journal of clinical oncology · 2023
   Article
3. COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in Italy.European journal of cancer (Oxford, England : 1990) · 2021
   Observational

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.